Austin Seniors Sought for Norovirus Vaccine Study
The Phase 3 clinical trial is enrolling 250 local participants to test an mRNA-based vaccine for the virus.
Updated on Oct. 21, 2026 in Nursing Jobs
Live Poll
Would you participate in a clinical trial to help test a new vaccine?
Austinites aged 60 and older are being recruited for a Phase 3 clinical trial testing an mRNA norovirus vaccine at Tekton Research. The global study, which is currently enrolling 250 local participants, aims to determine if the vaccine effectively prevents infection or reduces symptom severity in older adults.
Why it matters
Norovirus is a significant public health burden in the United States, causing up to 21 million annual cases and 100,000 hospitalizations. This trial seeks to gather data on a potential preventative measure, though researchers must still determine how long any resulting vaccine effectiveness might last.
Tekton Research is enrolling 250 local participants for a Phase 3 study that includes more than 37,000 global volunteers. The effectiveness of this mRNA vaccine against the estimated 19 million to 21 million U.S. cases remains to be determined.
The players
Tekton Research
An Austin-based research facility conducting clinical trials for new medical treatments.
The details
The trial requires participants to attend a preliminary eligibility visit followed by an injection visit, a follow-up, and regular symptom diary entries. Candidates must be 60 or older and cannot be taking immune-suppressing medications or have had norovirus in the last 30 days. Half of the participants will receive the vaccine, which uses mRNA to trigger antibody production without introducing the virus itself, while the other half will receive a placebo.
Timeline
Enrollment is currently ongoing as of October 2026.
Potential participants must not have had norovirus within the past 30 days.
The Texas Context
This trial utilizes mRNA technology, which follows a pattern set by the rapid development and deployment of COVID-19 vaccines. Researchers are now applying this platform to address norovirus, which remains a leading cause of severe gastrointestinal illness nationwide.
Seniors interested in participating can contact the research site to determine if they meet the eligibility criteria, which includes being 60 or older. Once enrolled, participants will need to commit to multiple clinic visits and maintain a symptom diary to assist with the study data collection.
The takeaway
The study aims to fill a critical gap in preventative care for a virus that causes 900 deaths annually in the U.S. Interested seniors should monitor local trial updates as researchers continue to process enrollment for the Austin site.
Further reading
For more information on the local medical research sector, visit the Nursing Jobs section.
Source note: This article includes information reported by Austin American-Statesman.
Live Poll
Would you participate in a clinical trial to help test a new vaccine?
